Aim: To investigate whether an antenatal surveillance protocol including ultrasound and cardiotocograph monitoring reduces intrauterine death (IUD) in cases of gastroschisis. Secondary outcomes included neonatal death rate, mode of delivery and rate of intervention before planned time of delivery. Methods: This was a retrospective observational study of all women with antenatally diagnosed gastroschisis who were managed according to the surveillance program between 2002 and 2015 in a tertiary fetal medicine and pediatric surgical center covering the Wessex region of England. We reviewed and analyzed data from the Wessex Antenatally Detected Anomalies (WANDA) database as well as prospectively managed maternity, ultrasound and neonatal databases over the given time period. Case notes were reviewed when delivery was expedited. Results: The IUD rate was 2.2%, a 58% reduction since the introduction of the surveillance protocol. Delivery was expedited in 35.4% of cases, and in 86% of these, delivery was by cesarean section. In women being induced as planned at 38 weeks, the vaginal delivery rate was 88%, and for those in spontaneous labor before 38 weeks it was 75%. Conclusions: An antenatal surveillance program appears to reduce the IUD in gastroschisis. In one-third of cases, delivery was indicated before the planned date of delivery. When expedited delivery was indicated, the chance of cesarean section was high.
Introduction
Gastroschisis is a congenital abdominal wall anomaly in which bowel and viscera protrude through a defect in the abdominal wall. The defect is typically to the right of a normally sited umbilicus. The prevalence of gastroschisis is increasing worldwide and is now around 4 per 10 000 total births in the UK. 1, 2 Despite the condition being associated with low birthweight, longterm developmental problems and intrauterine death (IUD), there is currently no recommended or standardized guidance for antenatal monitoring and delivery. 1, [3] [4] [5] Practice varies greatly with a wide range of antenatal monitoring regimens and delivery policies. 1, 3, 6, 7 In some units, all babies with gastroschisis are delivered by elective cesarean section. 6 In 1997, we reported an institutional IUD rate of 5.3%, and a literature review at that time showed a rate of between 9.5 and 12%. 8 In 2012, using capturerecapture analysis, Overton et al. reported an IUD rate of 4% in a UK-wide assessment of gastroschisis outcomes. 1 At the time of our previous publication, Wessex Fetal Medicine Unit, Southampton Hospital, UK had recently adopted a program of regular growth ultrasound (US) at 28, 32 and 36 weeks' gestation, with additional US if there are concerns about poor fetal growth; twice weekly cardiotocograph (CTG) monitoring from 34 weeks; and planned delivery at 38 weeks. 8, 9 This practice is now well established at the center and we wish to assess any changes in outcomes that may be attributable to this regimen. The standard practice in the Unit is for induction of labor with the aim of vaginal delivery unless there is another indication for cesarean section. Prior to this program, fetal monitoring and timing of delivery were at the discretion of individual clinicians, based on their assessments of the pregnancy. Overton et al. highlight the wide variation in UK-wide practice regarding fetal monitoring programs, and this variation also applies to the studies included in our literature review of the time. 1, 8 The primary aim was to investigate IUD at Wessex Fetal Medicine Unit following the introduction of the antenatal surveillance protocol. Secondary outcomes included mode of delivery, rate of intervention before planned time of delivery (by earlier induction of labor or emergency cesarean section) and neonatal death rate. We also examined the reason for earlier intervention to assess whether the antenatal surveillance was contributing to this.
Methods
We searched our regional congenital anomaly register, the Wessex Antenatally Detected Anomalies (WANDA) database, to identify all cases of gastroschisis. The register captures and records both antenatally and postnatally detected congenital anomalies for live births, stillbirths and terminations of pregnancy in the Wessex region, which covers 10 maternity services in central southern England and the Channel Islands. We report data for the last 13 years, encompassing births in the years 2002-2015. The data are obtained prospectively from the single regional fetal medicine unit on a weekly basis and from the neonatologists, surgeons, cardiologists and pathologists on a monthly basis, as well as from referrals to the Genetics service. Each of these specialties covers the Wessex region and sees virtually all cases detected within this area, so ascertainment rates are high. In addition, there are regular meetings with pediatricians and those carrying out prenatal diagnosis in the regional referral hospitals, which would identify cases referred out of region for management. Ethics approval to maintain and use the data in this register was obtained from the Trent Multicenter Research Ethics Committee (Ethics no. 09/H0405/48). Additional information about the prenatal and postnatal management and outcomes was then obtained from prospectively maintained databases (maternity database, ultrasound database, pathology reporting and the neonatal database). Patient notes were reviewed in cases of unplanned intervention.
We categorized outcomes of the pregnancy as the following: live birth, neonatal death, IUD (fetal loss beyond 23 weeks' gestation), miscarriage (fetal loss before 23 weeks) or termination of pregnancy. The delivery details were collated to demonstrate mode of delivery and whether this was planned, spontaneous or an intervention ahead of planned delivery for fetal concerns. This allowed us to determine the proportion of babies who needed intervention following antenatal surveillance. We further analyzed this group to try and identify which element of the antenatal surveillance led to this intervention (namely reduced fetal movements, US findings or CTG findings) and documented any trends in findings. Statistical analysis was performed using 2 × 2 tables and Fisherˈs exact test.
Results
Two hundred and twelve cases were identified. There were four cases of spontaneous miscarriage between 13 and 22 weeks' gestation, 13 terminations of pregnancy (of which eight involved complex anomalies not representative of isolated gastroschisis) and three cases of reclassification after live birth (to exomphalos; complex twin-twin transfusion syndrome; and multiple anomalies). Six infants moved out of the area and thus followed a different antenatal surveillance strategy and were excluded. We had limited data in a further five cases in which the delivery and neonatal care were transferred away from the present unit, although we do know that four of these involved live births. This left a total of 181 cases of gastroschisis in which the pregnancy continued beyond 23 weeks' gestation with adequate detail to assess (Fig. 1 ).
Of these 181, there were four IUD that occurred between 31 and 37 weeks' gestation, giving an overall IUD rate of 2.2% (95%CI: -0.2 to 4.6%). Two of these mothers had a history of substance abuse: one was known to have consumed excessive alcohol the night before the IUD was detected and the other was a known i.v. drug user but further details of the case are not known. A third mother attended for routine US at 36 weeks' gestation and was found to have an IUD. Reduced fetal movements had been noted the day before but these had subsequently improved. The fourth mother had an IUD at 33 weeks' gestation (before routine CTG monitoring started) and post-mortem indicated no abnormalities other than gastroschisis; this mother had noted reduced fetal movements for 48 h prior to this. She had had normal scans at 29 and 31 weeks of gestation. In all four cases, delivery was vaginal.
Two neonatal deaths occurred (1.1%). The first involved uncertain diagnosis, which may represent a possible exomphalos without a membrane. The other involved absent basal ganglia and fused thalami in addition to gastroschisis. The remaining infants survived the neonatal period (Table 1) .
Of the 177 pregnancies resulting in live births, 49 patients (27.1%) were induced at 38 weeks' gestation as planned, 56 (31%) went into spontaneous labor before 38 weeks' gestation, eight (4.4%) had an elective cesarean section for reasons not related to their diagnosis of gastroschisis (five for breech presentation, two for twin pregnancies and one for a failed induction at 38 weeks' gestation) and 64 (35.4%) had delivery expedited (by cesarean section or induction of labor) following the detection of suspected fetal compromise before the planned delivery date. These patients either attended for a routine scan or CTG or self-presented with reduced fetal movements ( Table 2) .
The trigger for earlier intervention in 64 patients was concerns at routine US in 23 (36%), concerns at routine CTG in 18 (28.1%), and presentation with reduced fetal movements in 21 (32.8%). In two cases (3.1%) details were unknown ( Table 3 ). All of those who presented with reduced fetal movements were subsequently delivered due to abnormal CTG, either directly at presentation or after a short period of inpatient surveillance. Seven of these patients were also noted to have US changes of bowel dilatation or stomach herniation. There is some evidence in the literature that these findings may be associated with intrapartum and postnatal complications. [10] [11] [12] Due to conflicting findings in the literature and a lack of large-scale prospective studies, however, these findings were not used alone to dictate timing of delivery and instead led to increased frequency of CTG monitoring, including as inpatients in some circumstances. In eight cases in which the decision was based on US or CTG, reduced fetal movements were also reported and three of these patients had delayed attending with reduced fetal movements because they knew they had a planned intervention (US or CTG) soon.
In the 49 patients induced at 38 weeks' gestation, 39 (79.6%) had a normal vaginal delivery (NVD), four (8.2%) had an instrumental delivery and six (12.2%) had an emergency cesarean section. Two of the six cesareans were for failure to progress in labor and the remainder were for suspected fetal compromise (Table 4) .
In the 56 patients who presented in spontaneous labor prior to their induction date, 38 (67.9%) had a normal vaginal delivery, one (1.8%) had a vaginal breech delivery, three (5.4%) had an instrumental delivery and 14 (25%) had an emergency cesarean section (six due to breech presentation and eight for suspected fetal compromise).
Regarding the group of patients for whom a decision was made to expedite delivery, induction of labor was attempted in 12 (18.8%). Of these, 10 achieved a vaginal delivery and two had an emergency cesarean section. In the remaining 52 patients, induction was not attempted and they had a cesarean section.
Discussion
The IUD rate fell from 5.3% to 2.2% of pregnancies continuing beyond 23 weeks (P = 0.36). This compares favorably with the 4% national figure generated by the British Association of Paediatric Surgeons Congenital Anomalies Surveillance System (BAPS-CASS) survey in 2012 1 for pregnancies surviving to the third trimester. The present IUD rate is lower, although there is not a statistically significant difference from the unadjusted 2.9% figure of their raw data (P = 0.77). During this time there has been a slight reduction in the background IUD rate (from 5.3 per 1000 in 1997 to 4.7 per 1000 in 2013). 13 The 58% reduction in IUD noted in the present study suggests that our protocol has been successful in lowering IUD rate for fetuses with gastroschisis. This trend gives us encouragement to continue our current practice of surveillance and elective induction at 38 weeks.
The antenatal surveillance strategy we use has several components, namely serial US, twice weekly CTG and increased maternal awareness of potential complications with heightened awareness of reduced fetal movements. This strategy led to expedited deliveries in 35.4% of cases. Each aspect of the surveillance program led to a significant fraction of these deliveries, demonstrating the importance of each component of the surveillance strategy.
The present results suggest that careful antenatal surveillance is of value and may reduce the IUD rate among fetuses with gastroschisis. They also emphasize the importance of maternal awareness, namely informing pregnant women to present early if they have concerns over fetal movements, despite the fact that they are having regular monitoring.
The emergency cesarean section rate was 41%, which is similar to that reported by this Unit in 1997. 8 In the group in which delivery was expedited, 84% of patients had an emergency cesarean section, comprising the majority of cases; but patients undergoing induction at 38 weeks' gestation achieved a vaginal delivery rate of 88%, and in those who went into spontaneous labor prior to 38 weeks' gestation, the vaginal delivery rate was 75%. This is an important observation because vaginal delivery has benefits for both mother and fetus over cesarean section and the concerns regarding subsequent pregnancies are particularly relevant in this population, who are often young and primiparous. 14- 19 The findings suggest that by having a policy of induction of labor at 38 weeks' gestation, we are not disadvantaging women, because the rates of successful vaginal delivery are high. Women should be counselled, however, that in 35% of cases, delivery will be sooner than planned, and in this situation, there is a high chance of having a cesarean section.
A recent meta-analysis by South et al. suggested avoiding delivery before 37 weeks' gestation in stable fetuses to avoid the risks associated with prematurity, and that there may be benefit in increased monitoring from 36 weeks' gestation. 7 This is in keeping with our current policy.
The present study benefits from the robust way in which cases are collected by WANDA, which means that the ascertainment rate is high and very few cases are lost to follow up (except when they moved out of region). Additionally, in the majority of the cases in which the baby was delivered out of area due to limited local cot capacity, we were still able to identify the birth outcome (as a minimum) with information from the maternity and neonatal databases.
The present findings support the notion that an antenatal surveillance protocol reduces the occurrence of IUD in fetuses with gastroschisis and leads to earlier delivery than planned when clinically indicated. A policy of aiming for vaginal delivery following induction of labor at 38 weeks' gestation does not appear to disadvantage women because the success rates are high, and this may result in benefits to both the mother and baby. One in three pregnancies with gastroschisis required delivery to be expedited because of concerns about fetal wellbeing, and in these cases there is an 84% chance of having a cesarean section. This information regarding mode of delivery should be included in prenatal counselling. Advising women about the importance of reporting reduced fetal movements at any gestation should be a key message when counselling them about gastroschisis, because 100% of those presenting with reduced fetal movements also had CTG or US abnormalities that led to delivery being expedited.
